Your cart is empty.
Zurich, Switzerland, April 20th 2007 – Tecan’s shareholders approved all motions of the board of directors during yesterday’s 2007 Annual General Meeting. However, due to a mistake in the compilation of the votes, the voting rights of a single large shareholder were not properly considered. This shareholder, who is subject to the 5% voting restriction based on Tecan’s articles of incorporation, supported the Board’s motions with all of his 602,367 authorized votes (equivalent to 5% of the votes).
Based on this fact, the results of the Annual General Meeting are to be corrected such that the motions of the Board were supported by an additional 602,367 votes.
Tecan (www.tecan.com) is a leading global supplier of solutions for the biopharma, forensic and diagnostic industries. The company is a leader in the development, production and distribution of advanced automation and detection solutions for the world’s leading life science laboratories. Through its REMP subsidiary (www.remp.com), Tecan is the premier supplier of large-scale automated laboratory storage and logistics systems. Founded in Switzerland in 1980, the company has over 1100 employees, owns production, research and development sites in both North America and Europe and maintains a sales and service network in 52 countries. In 2006, Tecan achieved sales of CHF 405.9 million (USD 324.7 million; EUR 258.6 million). Shares of the Tecan Group are traded on the SWX Swiss Exchange (TK: TECN/Reuters: TECZn.S/Valor: 1210019).
Tecan Group Ltd.